Choice of Method for Type 2 Diabetes Mellitus Prevention: as Pathogenetic Approach Using Voglibose
Journal Title: Міжнародний ендокринологічний журнал - Year 2014, Vol 7, Issue 63
Abstract
Aim. Substantiation of necessity of pathogenetic approach to the choice of method for type 2 diabetes mellitus prevention on the basis of studying clinical efficiency and tolerability of voglibose in persons with impaired glucose tolerance (IGT). Methods. We have observed 25 persons with IGT in age from 35 to 55 years. Clinical examination included measuring of height, body mass, body mass index (BMІ), waist circumference (WC), blood pressure, heart rate, glucose tolerance test, determination of glycated haemoglobin level, parameters of blood lipids, random level of immunoreactive insulin with evaluation of insulin resistance (IR) index after НОМА-IR equation and total cardiovascular risk after SCORE scale. Persons with IGT received voglibose (Voksid, produced by Kusum Pharm LLC, Ukraine) in a dose of 0.2 mg before breakfast, dinner and supper during three months. In 3 months we have carried out reexamination with the assessment of metabolic effects of preparation and study of total cardiovascular risk dynamics. Results. Antihyperglycemic therapy with voglibose in a dose 0.6 mg/day lead to the reliable decline of all basic parameters of carbohydrate metabolism, body mass, BMI and WC parameters, total cholesterol, triglycerides and low-density lipoprotein cholesterol levels. On completion of research on a background of voglibose use, a significant decrease of total cardiovascular risk by 29 % was marked. Three months voglibose therapy did not result in the change of hepatic enzymes (alanine aminotransferase and aspartate aminotransferase) activity, as well as symptoms of hypoglycemia. Conclusions. Antihyperglycemic therapy with voglibose for three months contributes to statistically significant decline of postprandial hyperglycaemia, fasting glucose and IR index in persons with IGT and high cardiovascular risk. Target glycemic level were achieved in 82.6 % of patients. Under the influence of voglibose therapy, predicted risk of fatal complications due to cardiovascular diseases in the next 10 years was significantly reduced by 29 %.
Authors and Affiliations
V. I. Pankiv, I. V. Chernyavska
Keywords
Related Articles
- EP ID EP229560
- DOI -
- Views 68
- Downloads 0
Insulin Therapy. What
The article deals with the need for insulin therapy in patients with diabetes mellitus (DM) type 2. In recent years, the indications for insulin therapy in patients with DM type 2 have increased significantly. According...
Hormonal Disorders as Significant Pathogenetic Factor of Acne in Women
Objective: to investigatie the features of hormonal disorders in women with acne. Materials and Methods. The study involved 126 women with acne aged 19 to 43 years, average age 32.23 ± 0.81 years. In plasma of venous bl...
Dynamics of acute phase indices in patients with rheumatoid arthritis combined with abdominal obesity, type 2 diabetes mellitus and arterial hypertension depending on Т-786С eNOS gene polymorphism following treatment
Background. The development of modern approaches to the pharmacotherapy of rheumatoid arthritis (RA) associated with abdominal obesity (AO), type 2 diabetes mellitus (DM 2) and arterial hypertension (AH) remains relevant...
Impact of Physical Activity on Dyslipidemia Onset in Children and Adolescents with Type 1 Diabetes Mellitus
The problem of treatment optimization for type 1 diabetes mellitus (DM) in children is not completely resolved so far, while recommendations concerning physical activity (PA) regimen usually do not consider the features...
Pathomorphological Changes of the Pancreas and Role of Vascular Factor in Insulin Deficiency Development in Diabetes Mellitus Type 2
The article presents current data on pathogenetic links of diabetes mellitus (DM) type 2 occurrence. A morphological study of pancreas vessels in patients with DM type 2 has been carried out. Specific changes in them as...